Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
-
最新报道：Pfizer reported Q2 2025 earnings of $1.42 per share, beating analyst estimates of $1.35, with revenue reaching $14.8 billion compared to the expected $14.3 billion. The pharmaceutical giant credited strong sales of its COVID-19 treatments and vaccines, along with growth in oncology and rare disease therapies. CEO Albert Bourla highlighted upcoming drug launches and pipeline advancements as key drivers for future growth. However, Pfizer lowered its full-year revenue guidance slightly to $60-$62 billion due to currency fluctuations. Shares rose 3% in pre-market trading following the earnings release.
下一篇
Galaxy Announces Second Quarter 2025 Financial Results
- Galaxy Digital Holdings Ltd. reported its Q2 2025 financial results, showcasing strong per...
24小时热点
热点专题
416833